On course for a cancer vaccine
- 3 June 1995
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 345 (8962) , 1384-1385
- https://doi.org/10.1016/s0140-6736(95)92592-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994
- Cancer antigens: immune recognition of self and altered self.The Journal of Experimental Medicine, 1994
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.Proceedings of the National Academy of Sciences, 1994
- Tumor Antigens Recognized by T LymphocytesAnnual Review of Immunology, 1994
- The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1993
- The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.The Journal of Experimental Medicine, 1990
- Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.Proceedings of the National Academy of Sciences, 1989
- Immunogenicity of melanoma‐associated gangliosides in cancer patientsInternational Journal of Cancer, 1985
- Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.The Journal of Experimental Medicine, 1982